Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Biol Bull ; 205(3): 331-8, 2003 Dec.
Article in English | MEDLINE | ID: mdl-14672987

ABSTRACT

Invertebrate hosts of chemoautotrophic symbionts face the unique challenge of supplying their symbionts with hydrogen sulfide while avoiding its toxic effects. The sulfur-containing free amino acids taurine and thiotaurine may function in sulfide detoxification by serving as sulfur storage compounds or as transport compounds between symbiont and host. After sulfide exposure, both taurine and thiotaurine levels increased in the gill tissues of the symbiotic coastal bivalve Solemya velum. Inhibition of prokaryotic metabolism with chloramphenicol, inhibition of eukaryotic metabolism with cycloheximide, and inhibition of ammonia assimilation with methionine sulfoximine reduced levels of sulfur-containing amino acids. Chloramphenicol treatment inhibited the removal of sulfide from the medium. In the absence of metabolic inhibitors, estimated rates of sulfide incorporation into taurine and thiotaurine accounted for nearly half of the sulfide removed from the medium. In contrast, amino acid levels in the nonsymbiotic, sulfide-tolerant molluscs Geukensia demissa and Yoldia limatula did not change after sulfide exposure. These findings suggest that sulfur-containing amino acids function in sulfide detoxification in symbiotic invertebrates, and that this process depends upon ammonia assimilation and symbiont metabolic capabilities.


Subject(s)
Amino Acids, Sulfur/biosynthesis , Bivalvia/metabolism , Sulfur/metabolism , Symbiosis , Taurine/biosynthesis , Amino Acids, Sulfur/drug effects , Animals , Bacterial Physiological Phenomena , Bivalvia/microbiology , Chloramphenicol/pharmacology , Cycloheximide/pharmacology , Gills/chemistry , Methionine Sulfoximine/pharmacology , Taurine/drug effects
2.
Pediatr Res ; 54(2): 276-81, 2003 Aug.
Article in English | MEDLINE | ID: mdl-12736393

ABSTRACT

Human neonates are uniquely susceptible to group B streptococcal (GBS) infections. We have shown that neonatal mixed mononuclear cells have a deficiency in the production of the T helper-1 (Th-1) cytokine, interferon gamma (IFN-gamma), and that incubation of neonatal neutrophils with recombinant IFN-gamma corrects these neutrophil defects. IL-12 and the more recently described IL-18 are also Th-1 type cytokines that are able to induce the production of IFN-gamma in the presence of bacteria and bacterial products. We examine the ability of GBS to induce the production of IFN-gamma, IL-18, and IL-12 by cord blood mixed mononuclear cells and compared these results with the IFN-gamma, IL-18, and IL-12 response of mixed mononuclear cells from adult blood. We demonstrate that cord blood mixed mononuclear cells produced significantly less IFN-gamma, IL-18, and IL-12 in response to GBS compared with mixed mononuclear cells from adults. Cord blood mixed mononuclear cells' production of IFN-gamma is enhanced by added recombinant IL-18 and IL-12. The maximal cord blood cell production of IFN-gamma, in response to GBS, is achieved by priming the cells with both IL-18 and IL-12. We conclude that neonatal mixed mononuclear cells exhibit deficiencies in three main Th-1 type cytokine responses, IFN-gamma, IL-12, and IL-18. This combined Th-1 type cytokine deficiency may contribute to the enhanced susceptibility of the human neonate to GBS and other microbial infections.


Subject(s)
Fetal Blood/cytology , Interferon-gamma/immunology , Interleukin-12/immunology , Interleukin-18/immunology , Streptococcal Infections/immunology , Streptococcus agalactiae/immunology , Th1 Cells/immunology , Adult , Antibodies, Monoclonal/pharmacology , Humans , In Vitro Techniques , Infant, Newborn , Interferon-gamma/metabolism , Interleukin-12/metabolism , Interleukin-18/metabolism , Th1 Cells/metabolism , Th1 Cells/microbiology
SELECTION OF CITATIONS
SEARCH DETAIL
...